AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2014

Aug 5, 2014

30016_dirs_2014-08-05_bbd21358-7815-4809-9c44-425887d303da.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2014-08-04

Reporting Person: AYERS JONATHAN W (Director, Chairman, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-08-04	Common Stock	M	10000	$28.655	Acquired	416036	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-08-04	Non-Qualified Stock Option (right to buy)	$28.655	M	10000	Disposed	2015-02-02	Common Stock (10000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	49000	Indirect

Footnotes

F1: Grant of options to buy shares of common stock exercisable as to 20,000 shares on each of 02/03/2006, 02/03/2007, 02/03/2008 and 02/03/2009 and 16,512 shares on 02/03/2010.